terazosin has been researched along with phenylpropanolamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, HZ; Wang, W; Xiao, H; Yang, Y; Zhang, X; Zhang, Y; Zhao, XF | 1 |
| Endeshaw, Y; Johnson, TM; Nagamia, Z; Ouslander, JG; Vaughan, CP | 1 |
1 trial(s) available for terazosin and phenylpropanolamine
| Article | Year |
|---|---|
Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzhydryl Compounds; Cresols; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prazosin; Prospective Studies; Prostatic Hyperplasia; Tolterodine Tartrate; Urination Disorders | 2007 |
1 other study(ies) available for terazosin and phenylpropanolamine
| Article | Year |
|---|---|
A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.
Topics: Acetamides; Adrenergic alpha-Antagonists; Aged; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Epidemiologic Methods; Humans; Hypnotics and Sedatives; Male; Middle Aged; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Prazosin; Prostatic Hyperplasia; Pyrimidines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2009 |